India · Delayed Price · Currency is INR Bafna Pharmaceuticals Statistics
Total Valuation
NSE:BAFNAPH has a market cap or net worth of INR 2.82 billion. The enterprise value is 3.14 billion.
| Market Cap | 2.82B |
| Enterprise Value | 3.14B |
Important Dates
The last earnings date was Wednesday, February 11, 2026.
| Earnings Date | Feb 11, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
NSE:BAFNAPH has 23.66 million shares outstanding. The number of shares has decreased by -0.14% in one year.
| Current Share Class | 23.66M |
| Shares Outstanding | 23.66M |
| Shares Change (YoY) | -0.14% |
| Shares Change (QoQ) | -0.52% |
| Owned by Insiders (%) | 4.97% |
| Owned by Institutions (%) | 4.36% |
| Float | 3.34M |
Valuation Ratios
The trailing PE ratio is 29.18.
| PE Ratio | 29.18 |
| Forward PE | n/a |
| PS Ratio | 1.91 |
| PB Ratio | 3.09 |
| P/TBV Ratio | 3.09 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | 32.53 |
| EV / Sales | 2.13 |
| EV / EBITDA | 19.39 |
| EV / EBIT | 27.57 |
| EV / FCF | n/a |
Financial Position
| Current Ratio | n/a |
| Quick Ratio | n/a |
| Debt / Equity | 0.36 |
| Debt / EBITDA | 2.00 |
| Debt / FCF | n/a |
| Interest Coverage | 3.47 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | n/a |
| Return on Invested Capital (ROIC) | 9.24% |
| Return on Capital Employed (ROCE) | n/a |
| Weighted Average Cost of Capital (WACC) | 4.68% |
| Revenue Per Employee | 3.63M |
| Profits Per Employee | 237,963 |
| Employee Count | 406 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +65.16% in the last 52 weeks. The beta is 0.01, so NSE:BAFNAPH's price volatility has been lower than the market average.
| Beta (5Y) | 0.01 |
| 52-Week Price Change | +65.16% |
| 50-Day Moving Average | 134.97 |
| 200-Day Moving Average | 117.59 |
| Relative Strength Index (RSI) | 47.65 |
| Average Volume (20 Days) | 3,174 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, NSE:BAFNAPH had revenue of INR 1.47 billion and earned 96.61 million in profits. Earnings per share was 4.09.
| Revenue | 1.47B |
| Gross Profit | 477.31M |
| Operating Income | 113.98M |
| Pretax Income | 96.61M |
| Net Income | 96.61M |
| EBITDA | 162.09M |
| EBIT | 113.98M |
| Earnings Per Share (EPS) | 4.09 |
Balance Sheet
The company has 2.54 million in cash and 324.03 million in debt, with a net cash position of -321.48 million or -13.59 per share.
| Cash & Cash Equivalents | 2.54M |
| Total Debt | 324.03M |
| Net Cash | -321.48M |
| Net Cash Per Share | -13.59 |
| Equity (Book Value) | 912.28M |
| Book Value Per Share | 38.54 |
| Working Capital | n/a |
Cash Flow
| Operating Cash Flow | n/a |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
Gross margin is 32.37%, with operating and profit margins of 7.73% and 6.55%.
| Gross Margin | 32.37% |
| Operating Margin | 7.73% |
| Pretax Margin | 6.55% |
| Profit Margin | 6.55% |
| EBITDA Margin | 10.99% |
| EBIT Margin | 7.73% |
| FCF Margin | n/a |
Dividends & Yields
NSE:BAFNAPH does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 0.14% |
| Shareholder Yield | 0.14% |
| Earnings Yield | 3.42% |
| FCF Yield | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 2 |